摘要:
Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with pi 110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.
摘要:
Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110 activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.
摘要:
Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of CDK4-mediated disorders, such as cancer. The subject compounds are gem-disubstituted or spirocyclic pyridine, pyrimidine and triazine derivatives.
摘要:
A method of forming a cross-correlation function R ( τ ) = ∑ N 2 k = N 1 r ( k ) m ( k - τ ) , mathematically as an inner product of the samples of a received signal r(t) and a replica of the signal modulation function m(t), with a computational burden reduced by many orders of magnitude in pseudonoise (PN) coded ranging applications is accomplished by a two step process. First, a single weighted sum of the signal samples forms a small dimension vector, of the order of tens of elements. Second, the inner product of this vector and vectors of the same dimension of samples of the signal modulation generating function, delayed by arbitrarily many values of the delay parameter τ, result in fine delay resolution correlation function values. The process comparatively entails a relatively small computational burden, does not compromise fidelity, and makes real-time optimal range estimation practical.
摘要:
Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of CDK4-mediated disorders, such as cancer. The subject compounds are fused pyridine, pyrimide and triazine derivatives.
摘要:
A process is disclosed for discriminating between received ranging signals, such as GPS, GNSS, and radar signals, which arrive via a single path and those which arrive via multiple paths. The number of paths is also estimated. This is accomplished by comparing the residual for an ith order ML estimator of signal time of arrival, where order refers to the number of signal paths for which the estimator is optimal, to a discriminant determined either analytically or empirically and deciding that i distinct signal path components are present in the observation of the signal if for all kth order estimators where k
摘要:
A method for mitigating multipath effects in radio systems which is based on searching for and finding a maximum likelihood estimate of range for a received signal is provided. In determining the maximum likelihood estimate, the correlation process uses a high resolution step method in processing the received signal sample values to develop an estimation statistic. The estimation statistic using the correlations of the received signal is based on a new derived representative set of coefficients formed from a nonlinear combination of parameters of the received signal transformed into a linearly solvable invertible parameter set allowing solution of the maximization process of the estimation statistic over a reduced dimension search space. Additionally there is a method of constraining the relative amplitude of received secondary signals to obtain a refinement of the optimal solution of range. The method includes a process to reduce the magnitude of the processing required by the receiver by reducing the size of the overall sample of the signal that must be managed by the receiver. The method may be used in a signal environment where multiple secondary path signals are received by the signal ranging system.
摘要:
This invention involves a method for mitigating multipath effects in radio ranging systems which is based on searching for and finding a maximum likelihood estimate of range for a received signal in a signal ranging system. In determining the maximum likelihood estimate, the correlation process uses a high resolution step method in processing the received signal sample values to develop an estimation statistic. The estimation statistic using the correlations of the received signal is based on a new derived representative set of coefficients formed from a nonlinear combination of parameters of the received signal transformed into an invertible linear combination which allows solution of the maximization process of the estimation statistic. Additionally there is a method of constraining the relative amplitude of received secondary signals to obtain a refinement of the optimal solution of range. Also the method includes a process to reduce the magnitude of the processing required by the receiver by reducing the size of the overall sample of the signal that must be managed by the receiver. The method may be used in a signal environment where multiple secondary path signals are received by the signal ranging system.
摘要:
Anchor deployment systems, anchor deployment devices, and methods of treatment are described herein. An embodiment of an anchor deployment system comprises a deployment device, a retention mechanism, an anchor, and a connector. The deployment device has a handle, an elongate member, a stylet, a spring, and an actuator. The deployment device has a first configuration in which the connector is releasably attached to the handle and a second configuration in which the connector is free of attachment to the handle.
摘要:
Selected compounds are effective for prophylaxis and treatment of inflammation and inflammatory disorders, such as NIK-mediated disorders. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, inflammation and the like.